Free Trial

Regulus Therapeutics (RGLS) SEC Filings & 10K Form

Regulus Therapeutics logo
$1.47 +0.07 (+5.00%)
(As of 11/22/2024 ET)

Recent Regulus Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:32 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
11/14/2024
1:35 PM
DAFNA Capital Management LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
11/07/2024
3:26 PM
Regulus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:02 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
08/08/2024
3:24 PM
Regulus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
3:18 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:23 AM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
3:20 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:21 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:21 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:16 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:33 PM
Huang Alice Shih-hou (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:54 PM
Regulus Therapeutics (Filer)
Form 424B5
04/21/2024
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
04/19/2024
3:13 PM
Regulus Therapeutics (Filer)
Form ARS
04/10/2024
9:06 AM
FMR LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
04/09/2024
3:55 PM
Regulus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/25/2024
3:18 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
03/22/2024
3:03 PM
Deep Track Capital, LP (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
03/21/2024
3:28 PM
Regulus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
3:18 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:30 PM
Regulus Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
03/18/2024
8:13 PM
Growth Equity Opportunities V, LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13D/A
03/15/2024
3:19 PM
PAPADOPOULOS STELIOS (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
3:57 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:49 AM
FMR LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:06 AM
Regulus Therapeutics (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
01/18/2024
7:22 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:23 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:24 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
9:25 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
01/17/2024
4:16 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
4:18 PM
Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
4:04 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
4:08 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:11 PM
Regulus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/09/2024
11:15 PM
Regulus Therapeutics (Filer)
Form EFFECT
12/27/2023
3:16 PM
Regulus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGLS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners